Literature DB >> 64244

Properties of erythrocyte catalase from homozygotes and heterozygotes for Swiss-type acatalasemia.

H Aebi, S R Wyss, B Scherz, J Gross.   

Abstract

The unstable catalase variant found in the blood of individuals homozygous for Swiss-type acatalasemia and the enzyme species present in heterozygous carriers of this rare defect have been further characterized. The mutant enzyme isolated from acatalasemic red cells is considerably more heat labile and differs in electrophoretic mobility from the normal enzyme. Catalase preparations obtained from heterozygotes consist of an apparently uniform enzyme species, probably representing a molecular hybrid, with properties intermediate to those of the normal and the variant enzyme. However, antigenic identity of catalase from all three sources is observed. Model experiments indicate that hybrid catalase molecules can be produced by recombining normal and variant dimer subunits. Fractionation of erythrocytes according to density and age shows that most of the residual catalase activity is localized in juvenile acatalasemic cells, whereas in normal and heterozygous individuals the catalase activity level does not alter significantly during the life span of the red cells. These findings agree with the observation that there is no gene dosage in heterozygotes, their catalase activity values falling within the normal range.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 64244     DOI: 10.1007/BF00485342

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  21 in total

1.  Catalase activity in young red cells.

Authors:  M D SASS
Journal:  Nature       Date:  1963-02-02       Impact factor: 49.962

2.  Two cases of acatalasia in Switzerland.

Authors:  H AEBI; J P HEINIGER; R BUETLER; A HAESSIG
Journal:  Experientia       Date:  1961-10-15

3.  An improved procedure for starch-gel electrophoresis: further variations in the serum proteins of normal individuals.

Authors:  O SMITHIES
Journal:  Biochem J       Date:  1959-03       Impact factor: 3.857

4.  Catalatic activity of immature and mature red blood cells in Japanese acatalasemia (difference between Japanese and Swiss acatalasemia).

Authors:  M Ogata; K Tomokuni; S Takahara
Journal:  Acta Med Okayama       Date:  1969-10       Impact factor: 0.892

5.  Residual catalase in the blood of Japanese acatalasemia.

Authors:  M Ogata; K Tomokuni; S Watanabe; H Osaki; M Sadamoto
Journal:  Tohoku J Exp Med       Date:  1972-06       Impact factor: 1.848

6.  Actalasemia and hypocatalasemia in the Orient.

Authors:  S Takahara
Journal:  Semin Hematol       Date:  1971-10       Impact factor: 3.851

7.  Heterogeneity of erythrocyte catalase II. Isolation and characterization of normal and variant erythrocyte catalase and their subunits.

Authors:  H Aebi; S R Wyss; B Scherz; F Skvaril
Journal:  Eur J Biochem       Date:  1974-10-01

8.  Specific immunoassay for quantitative determination of human erythrocyte catalase.

Authors:  Y Ben-Yoseph; E Shapira
Journal:  J Lab Clin Med       Date:  1973-01

9.  [On the cellular distribution of catalase in the blood of homozygous and heterozygous defect-carriers (acatalasia)].

Authors:  H Aebi; M Cantz
Journal:  Humangenetik       Date:  1966

10.  Properties of leukocyte catalase in Swiss type acatalasemia: a comparative study of normals, heterozygotes and homozygotes.

Authors:  S R Wyss; H Aebi
Journal:  Enzyme       Date:  1975
View more
  18 in total

1.  Properties of residual catalase in the erythrocytes of Japanese-type acatalasemia.

Authors:  M Ogata; J Mizugaki
Journal:  Hum Genet       Date:  1979-05-10       Impact factor: 4.132

2.  Heterogeneity of erythrocyte catalase in Japanese-type acatalasemia by electrofocusing.

Authors:  M Ogata; J Mizugaki
Journal:  Biochem Genet       Date:  1982-04       Impact factor: 1.890

3.  Protective effects of radon inhalation on carrageenan-induced inflammatory paw edema in mice.

Authors:  Takahiro Kataoka; Junichi Teraoka; Akihiro Sakoda; Yuichi Nishiyama; Keiko Yamato; Mayuko Monden; Yuu Ishimori; Takaharu Nomura; Takehito Taguchi; Kiyonori Yamaoka
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

4.  Inhibitory effects of prior low-dose X-irradiation on cold-induced brain injury in mouse.

Authors:  Masaaki Yoshimoto; Takahiro Kataoka; Teruaki Toyota; Takehito Taguchi; Kiyonori Yamaoka
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

5.  Hesperidin Preserves Cognitive Functions and Hippocampus Histological Architecture in Albino Wistar Rats Subjected to Stress Through Enhancement of Brain-Derived Neurotrophic Factor.

Authors:  Ahmed S Ahmed; Marwa M Mona; Rasha A Elsisy; Ehab M Hantash
Journal:  Neurotox Res       Date:  2021-11-26       Impact factor: 3.911

6.  Protection of human neutrophils by endogenous catalase: studies with cells from catalase-deficient individuals.

Authors:  D Roos; R S Weening; S R Wyss; H E Aebi
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

7.  Antinociceptive effects of radon inhalation on formalin-induced inflammatory pain in mice.

Authors:  Keiko Yamato; Takahiro Kataoka; Yuichi Nishiyama; Takehito Taguchi; Kiyonori Yamaoka
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

Review 8.  Acatalasemia.

Authors:  M Ogata
Journal:  Hum Genet       Date:  1991-02       Impact factor: 4.132

9.  Basic study on active changes in biological function of mouse liver graft in cold storage after low-dose x-irradiation.

Authors:  Takahiro Kataoka; Masaaki Yoshimoto; Shinya Nakagawa; Yuko Mizuguchi; Takehito Taguchi; Kiyonori Yamaoka
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

10.  Comparative study on the inhibitory effects of antioxidant vitamins and radon on carbon tetrachloride-induced hepatopathy.

Authors:  Takahiro Kataoka; Yuichi Nishiyama; Keiko Yamato; Junichi Teraoka; Yuji Morii; Akihiro Sakoda; Yuu Ishimori; Takehito Taguchi; Kiyonori Yamaoka
Journal:  J Radiat Res       Date:  2012-07-31       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.